Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 271

1.

Subclinical hypothyroidism is linked to micro-inflammation and predicts death in continuous ambulatory peritoneal dialysis.

Enia G, Panuccio V, Cutrupi S, Pizzini P, Tripepi G, Mallamaci F, Zoccali C.

Nephrol Dial Transplant. 2007 Feb;22(2):538-44. Epub 2006 Nov 2.

PMID:
17082213
2.

Selected growth factors in peritoneal dialysis: their relationship to markers of inflammation, dialysis adequacy, residual renal function, and peritoneal membrane transport.

Stompór T, Zdzienicka A, Motyka M, Dembińska-Kieć A, Davies SJ, Sulowicz W.

Perit Dial Int. 2002 Nov-Dec;22(6):670-6.

PMID:
12556068
3.

[Can FT3 levels facilitate the detection of inflammation or catabolism and malnutrition in dialysis patients?].

Fernández-Reyes MJ, Sánchez R, Heras M, Tajada P, Iglesias P, García L, García Arévalo MC, Molina A, Rodríguez A, Alvarez-Ude F.

Nefrologia. 2009;29(4):304-10. doi: 10.3265/Nefrologia.2009.29.4.5162.en.full. Spanish.

4.

Peritoneal transport status influence on atherosclerosis/inflammation in CAPD patients.

Sezer S, Tutal E, Arat Z, Akçay A, Celik H, Ozdemir FN, Haberal M.

J Ren Nutr. 2005 Oct;15(4):427-34.

PMID:
16198934
5.

Relationship between triiodothyronine and proinflammatory cytokines in chronic heart failure.

Lubrano V, Pingitore A, Carpi A, Iervasi G.

Biomed Pharmacother. 2010 Mar;64(3):165-9. doi: 10.1016/j.biopha.2009.09.001. Epub 2009 Oct 27.

PMID:
19926244
6.

Can the inflammation markers of patients with high peritoneal permeability on continuous ambulatory peritoneal dialysis be reduced on nocturnal intermittent peritoneal dialysis?

Cueto-Manzano AM, Rojas-Campos E, Martínez-Ramírez HR, Valera-González I, Medina M, Monteón F, Ruiz N, Becerra M, Palomeque MA, Cortés-Sanabria L.

Perit Dial Int. 2006 May-Jun;26(3):341-8.

PMID:
16722027
7.

IL-18 is involved in vascular injury in end-stage renal disease patients.

Porazko T, Kúzniar J, Kusztal M, Kúzniar TJ, Weyde W, Kuriata-Kordek M, Klinger M.

Nephrol Dial Transplant. 2009 Feb;24(2):589-96. doi: 10.1093/ndt/gfn486. Epub 2008 Sep 4.

PMID:
18775894
8.

Low triiodothyronine: a new facet of inflammation in end-stage renal disease.

Zoccali C, Tripepi G, Cutrupi S, Pizzini P, Mallamaci F.

J Am Soc Nephrol. 2005 Sep;16(9):2789-95. Epub 2005 Jul 20.

9.

Chronic inflammation and mortality in haemodialysis: effect of different renal replacement therapies. Results from the RISCAVID study.

Panichi V, Rizza GM, Paoletti S, Bigazzi R, Aloisi M, Barsotti G, Rindi P, Donati G, Antonelli A, Panicucci E, Tripepi G, Tetta C, Palla R; RISCAVID Study Group.

Nephrol Dial Transplant. 2008 Jul;23(7):2337-43. doi: 10.1093/ndt/gfm951. Epub 2008 Feb 27.

PMID:
18305316
10.

Associations of serum fetuin-A with malnutrition, inflammation, atherosclerosis and valvular calcification syndrome and outcome in peritoneal dialysis patients.

Wang AY, Woo J, Lam CW, Wang M, Chan IH, Gao P, Lui SF, Li PK, Sanderson JE.

Nephrol Dial Transplant. 2005 Aug;20(8):1676-85. Epub 2005 May 17.

PMID:
15899935
11.

Association between serum albumin and mortality in dialysis patients is partly explained by inflammation, and not by malnutrition.

de Mutsert R, Grootendorst DC, Indemans F, Boeschoten EW, Krediet RT, Dekker FW; Netherlands Cooperative Study on the Adequacy of Dialysis-II Study Group.

J Ren Nutr. 2009 Mar;19(2):127-35. doi: 10.1053/j.jrn.2008.08.003.

PMID:
19218039
12.

Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD.

Honda H, Qureshi AR, Heimbürger O, Barany P, Wang K, Pecoits-Filho R, Stenvinkel P, Lindholm B.

Am J Kidney Dis. 2006 Jan;47(1):139-48.

PMID:
16377395
14.

Resting energy expenditure and subsequent mortality risk in peritoneal dialysis patients.

Wang AY, Sea MM, Tang N, Sanderson JE, Lui SF, Li PK, Woo J.

J Am Soc Nephrol. 2004 Dec;15(12):3134-43.

15.

Peritoneal fast transport in incident peritoneal dialysis patients is not consistently associated with systemic inflammation.

Rodrigues AS, Almeida M, Fonseca I, Martins M, Carvalho MJ, Silva F, Correia C, Santos MJ, Cabrita A.

Nephrol Dial Transplant. 2006 Mar;21(3):763-9. Epub 2005 Dec 6.

PMID:
16332703
16.

C reactive protein in patients with chronic renal diseases.

Panichi V, Migliori M, De Pietro S, Taccola D, Bianchi AM, Norpoth M, Metelli MR, Giovannini L, Tetta C, Palla R.

Ren Fail. 2001 May-Jul;23(3-4):551-62.

PMID:
11499569
17.

Interleukin-6 is an independent predictor of mortality in patients starting dialysis treatment.

Pecoits-Filho R, Bárány P, Lindholm B, Heimbürger O, Stenvinkel P.

Nephrol Dial Transplant. 2002 Sep;17(9):1684-8.

PMID:
12198224
18.

Peritoneal transport characteristics, comorbid diseases and survival in CAPD patients.

Chung SH, Chu WS, Lee HA, Kim YH, Lee IS, Lindholm B, Lee HB.

Perit Dial Int. 2000 Sep-Oct;20(5):541-7.

PMID:
11117245
19.

The circulating soluble TRAIL is a negative marker for inflammation inversely associated with the mortality risk in chronic kidney disease patients.

Liabeuf S, Barreto DV, Barreto FC, Chasseraud M, Brazier M, Choukroun G, Kamel S, Massy ZA.

Nephrol Dial Transplant. 2010 Aug;25(8):2596-602. doi: 10.1093/ndt/gfq042. Epub 2010 Feb 26.

PMID:
20190248
20.

The effects of peritoneal dialysis and hemodialysis on serum tumor necrosis factor-alpha, interleukin-6, interleukin-10 and C-reactive-protein levels.

Borazan A, Ustün H, Ustundag Y, Aydemir S, Bayraktaroglu T, Sert M, Yilmaz A.

Mediators Inflamm. 2004 Jun;13(3):201-4.

Supplemental Content

Support Center